↓ Skip to main content

New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer

Overview of attention for article published in Journal of Translational Medicine, March 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter
2 X users
patent
2 patents

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
95 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer
Published in
Journal of Translational Medicine, March 2012
DOI 10.1186/1479-5876-10-48
Pubmed ID
Authors

David F Stroncek, Carolina Berger, Martin A Cheever, Richard W Childs, Mark E Dudley, Peter Flynn, Luca Gattinoni, James R Heath, Michael Kalos, Francesco M Marincola, Jeffrey S Miller, Gustavo Mostoslavsky, Daniel J Powell, Mahendra Rao, Nicholas P Restifo, Steven A Rosenberg, John O'Shea, Cornelis JM Melief

Abstract

A summit on cellular therapy for cancer discussed and presented advances related to the use of adoptive cellular therapy for melanoma and other cancers. The summit revealed that this field is advancing rapidly. Conventional cellular therapies, such as tumor infiltrating lymphocytes (TIL), are becoming more effective and more available. Gene therapy is becoming an important tool in adoptive cell therapy. Lymphocytes are being engineered to express high affinity T cell receptors (TCRs), chimeric antibody-T cell receptors (CARs) and cytokines. T cell subsets with more naïve and stem cell-like characteristics have been shown in pre-clinical models to be more effective than unselected populations and it is now possible to reprogram T cells and to produce T cells with stem cell characteristics. In the future, combinations of adoptive transfer of T cells and specific vaccination against the cognate antigen can be envisaged to further enhance the effectiveness of these therapies.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 1%
Netherlands 1 1%
South Africa 1 1%
Mexico 1 1%
United States 1 1%
Unknown 90 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 26 27%
Researcher 22 23%
Student > Master 9 9%
Student > Bachelor 7 7%
Professor 6 6%
Other 15 16%
Unknown 10 11%
Readers by discipline Count As %
Agricultural and Biological Sciences 37 39%
Medicine and Dentistry 28 29%
Biochemistry, Genetics and Molecular Biology 4 4%
Immunology and Microbiology 4 4%
Nursing and Health Professions 2 2%
Other 8 8%
Unknown 12 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 April 2020.
All research outputs
#4,032,012
of 22,664,644 outputs
Outputs from Journal of Translational Medicine
#638
of 3,954 outputs
Outputs of similar age
#26,515
of 156,793 outputs
Outputs of similar age from Journal of Translational Medicine
#4
of 50 outputs
Altmetric has tracked 22,664,644 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,954 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 156,793 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.